These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 11673469
1. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. Eberhardy SR, Farnham PJ. J Biol Chem; 2001 Dec 21; 276(51):48562-71. PubMed ID: 11673469 [Abstract] [Full Text] [Related]
2. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. Eberhardy SR, D'Cunha CA, Farnham PJ. J Biol Chem; 2000 Oct 27; 275(43):33798-805. PubMed ID: 10931841 [Abstract] [Full Text] [Related]
3. Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Boyd KE, Farnham PJ. Mol Cell Biol; 1997 May 27; 17(5):2529-37. PubMed ID: 9111322 [Abstract] [Full Text] [Related]
7. Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters. Hoque M, Mathews MB, Pe'ery T. J Cell Physiol; 2010 Apr 27; 223(1):224-33. PubMed ID: 20054825 [Abstract] [Full Text] [Related]
8. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. Eberhardy SR, Farnham PJ. J Biol Chem; 2002 Oct 18; 277(42):40156-62. PubMed ID: 12177005 [Abstract] [Full Text] [Related]
9. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Pal S, Yun R, Datta A, Lacomis L, Erdjument-Bromage H, Kumar J, Tempst P, Sif S. Mol Cell Biol; 2003 Nov 18; 23(21):7475-87. PubMed ID: 14559996 [Abstract] [Full Text] [Related]
13. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J, Cole M. Genes Dev; 1998 Dec 15; 12(24):3797-802. PubMed ID: 9869632 [Abstract] [Full Text] [Related]
14. CAD gene sequence and the domain structure of the mammalian multifunctional protein CAD. Evans DR, Bein K, Guy HI, Liu X, Molina JA, Zimmermann BH. Biochem Soc Trans; 1993 Feb 15; 21(1):186-91. PubMed ID: 8095469 [No Abstract] [Full Text] [Related]
15. P-TEFb is a crucial co-factor for Myc transactivation. Gargano B, Amente S, Majello B, Lania L. Cell Cycle; 2007 Aug 15; 6(16):2031-7. PubMed ID: 17700062 [Abstract] [Full Text] [Related]
16. Identification of a phylogenetically conserved Sug1 CAD family member that is differentially expressed in the mouse nervous system. Sun D, Swaffield JC, Johnston SA, Milligan CE, Zoeller RT, Schwartz LM. J Neurobiol; 1997 Dec 15; 33(7):877-90. PubMed ID: 9407011 [Abstract] [Full Text] [Related]
17. Function of the polypeptide chain segment connecting the dihydroorotase and aspartate transcarbamylase domains in the mammalian multifunctional CAD. Guy HI, Evans DR. Adv Exp Med Biol; 1994 Dec 15; 370():729-33. PubMed ID: 7661008 [No Abstract] [Full Text] [Related]
18. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR. Mol Cell Biol; 1998 Jan 15; 18(1):536-45. PubMed ID: 9418900 [Abstract] [Full Text] [Related]